Global Laryngeal Cancer Therapeutics Market 2023-2027

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4.1 Global laryngeal cancer therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global laryngeal cancer therapeutics market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Biologics - Market size and forecast 2022-2027
Exhibit 34: Chart on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Biologics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
6.4 Small molecules - Market size and forecast 2022-2027
Exhibit 38: Chart on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 56: Market opportunity by Distribution Channel ($ million)
Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 83: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 107: Amgen Inc. - Overview
Exhibit 108: Amgen Inc. - Product/Service
Exhibit 109: Amgen Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 110: AstraZeneca Plc - Overview
Exhibit 111: AstraZeneca Plc - Product/Service
Exhibit 112: AstraZeneca Plc - Key news
Exhibit 113: AstraZeneca Plc - Key offerings
12.5 Bayer AG
Exhibit 114: Bayer AG - Overview
Exhibit 115: Bayer AG - Business segments
Exhibit 116: Bayer AG - Key news
Exhibit 117: Bayer AG - Key offerings
Exhibit 118: Bayer AG - Segment focus
12.6 Bristol Myers Squibb Co.
Exhibit 119: Bristol Myers Squibb Co. - Overview
Exhibit 120: Bristol Myers Squibb Co. - Product/Service
Exhibit 121: Bristol Myers Squibb Co. - Key news
Exhibit 122: Bristol Myers Squibb Co. - Key offerings
12.7 Celldex Therapeutics Inc.
Exhibit 123: Celldex Therapeutics Inc. - Overview
Exhibit 124: Celldex Therapeutics Inc. - Product/Service
Exhibit 125: Celldex Therapeutics Inc. - Key offerings
12.8 Eli Lilly and Co.
Exhibit 126: Eli Lilly and Co. - Overview
Exhibit 127: Eli Lilly and Co. - Product/Service
Exhibit 128: Eli Lilly and Co. - Key news
Exhibit 129: Eli Lilly and Co. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 130: F. Hoffmann La Roche Ltd. - Overview
Exhibit 131: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 132: F. Hoffmann La Roche Ltd. - Key news
Exhibit 133: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 134: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Hangzhou Adlai Nortye Biopharma Co. Ltd.
Exhibit 135: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Overview
Exhibit 136: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Product/Service
Exhibit 137: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Key offerings
12.11 Hanmi Pharm Co. Ltd.
Exhibit 138: Hanmi Pharm Co. Ltd. - Overview
Exhibit 139: Hanmi Pharm Co. Ltd. - Product/Service
Exhibit 140: Hanmi Pharm Co. Ltd. - Key offerings
12.12 Hikma Pharmaceuticals Plc
Exhibit 141: Hikma Pharmaceuticals Plc - Overview
Exhibit 142: Hikma Pharmaceuticals Plc - Business segments
Exhibit 143: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 144: Hikma Pharmaceuticals Plc - Segment focus
12.13 Merck and Co. Inc.
Exhibit 145: Merck and Co. Inc. - Overview
Exhibit 146: Merck and Co. Inc. - Business segments
Exhibit 147: Merck and Co. Inc. - Key news
Exhibit 148: Merck and Co. Inc. - Key offerings
Exhibit 149: Merck and Co. Inc. - Segment focus
12.14 Pfizer Inc.
Exhibit 150: Pfizer Inc. - Overview
Exhibit 151: Pfizer Inc. - Product/Service
Exhibit 152: Pfizer Inc. - Key news
Exhibit 153: Pfizer Inc. - Key offerings
12.15 Regeneron Pharmaceuticals Inc.
Exhibit 154: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 155: Regeneron Pharmaceuticals Inc. - Product/Service
Exhibit 156: Regeneron Pharmaceuticals Inc. - Key offerings
12.16 Sanofi
Exhibit 157: Sanofi - Overview
Exhibit 158: Sanofi - Business segments
Exhibit 159: Sanofi - Key news
Exhibit 160: Sanofi - Key offerings
Exhibit 161: Sanofi - Segment focus
12.17 Sun Pharmaceutical Industries Ltd.
Exhibit 162: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 163: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibit 164: Sun Pharmaceutical Industries Ltd. - Key offerings

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global laryngeal cancer therapeutics market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Distribution Channel
Exhibits 47: Data Table on Comparison by Distribution Channel
Exhibits 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits 56: Market opportunity by Distribution Channel ($ million)
Exhibits 57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ million)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 101: Impact of drivers and challenges in 2022 and 2027
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Amgen Inc. - Overview
Exhibits 108: Amgen Inc. - Product/Service
Exhibits 109: Amgen Inc. - Key offerings
Exhibits 110: AstraZeneca Plc - Overview
Exhibits 111: AstraZeneca Plc - Product/Service
Exhibits 112: AstraZeneca Plc - Key news
Exhibits 113: AstraZeneca Plc - Key offerings
Exhibits 114: Bayer AG - Overview
Exhibits 115: Bayer AG - Business segments
Exhibits 116: Bayer AG - Key news
Exhibits 117: Bayer AG - Key offerings
Exhibits 118: Bayer AG - Segment focus
Exhibits 119: Bristol Myers Squibb Co. - Overview
Exhibits 120: Bristol Myers Squibb Co. - Product/Service
Exhibits 121: Bristol Myers Squibb Co. - Key news
Exhibits 122: Bristol Myers Squibb Co. - Key offerings
Exhibits 123: Celldex Therapeutics Inc. - Overview
Exhibits 124: Celldex Therapeutics Inc. - Product/Service
Exhibits 125: Celldex Therapeutics Inc. - Key offerings
Exhibits 126: Eli Lilly and Co. - Overview
Exhibits 127: Eli Lilly and Co. - Product/Service
Exhibits 128: Eli Lilly and Co. - Key news
Exhibits 129: Eli Lilly and Co. - Key offerings
Exhibits 130: F. Hoffmann La Roche Ltd. - Overview
Exhibits 131: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 132: F. Hoffmann La Roche Ltd. - Key news
Exhibits 133: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 134: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 135: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Overview
Exhibits 136: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Product/Service
Exhibits 137: Hangzhou Adlai Nortye Biopharma Co. Ltd. - Key offerings
Exhibits 138: Hanmi Pharm Co. Ltd. - Overview
Exhibits 139: Hanmi Pharm Co. Ltd. - Product/Service
Exhibits 140: Hanmi Pharm Co. Ltd. - Key offerings
Exhibits 141: Hikma Pharmaceuticals Plc - Overview
Exhibits 142: Hikma Pharmaceuticals Plc - Business segments
Exhibits 143: Hikma Pharmaceuticals Plc - Key offerings
Exhibits 144: Hikma Pharmaceuticals Plc - Segment focus
Exhibits 145: Merck and Co. Inc. - Overview
Exhibits 146: Merck and Co. Inc. - Business segments
Exhibits 147: Merck and Co. Inc. - Key news
Exhibits 148: Merck and Co. Inc. - Key offerings
Exhibits 149: Merck and Co. Inc. - Segment focus
Exhibits 150: Pfizer Inc. - Overview
Exhibits 151: Pfizer Inc. - Product/Service
Exhibits 152: Pfizer Inc. - Key news
Exhibits 153: Pfizer Inc. - Key offerings
Exhibits 154: Regeneron Pharmaceuticals Inc. - Overview
Exhibits 155: Regeneron Pharmaceuticals Inc. - Product/Service
Exhibits 156: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits 157: Sanofi - Overview
Exhibits 158: Sanofi - Business segments
Exhibits 159: Sanofi - Key news
Exhibits 160: Sanofi - Key offerings
Exhibits 161: Sanofi - Segment focus
Exhibits 162: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 163: Sun Pharmaceutical Industries Ltd. - Product/Service
Exhibits 164: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 165: Inclusions checklist
Exhibits 166: Exclusions checklist
Exhibits 167: Currency conversion rates for US$
Exhibits 168: Research methodology
Exhibits 169: Validation techniques employed for market sizing
Exhibits 170: Information sources
Exhibits 171: List of abbreviations